Utilizing Scottish national population-based data, a retrospective cohort study was performed to explore the risk of melanoma in women with endometriosis.
Publications
Predictors of nonsentinel lymph node metastasis in cutaneous melanoma: A systematic review and meta-analysis
Researchers aimed to determine risk factors that can predict the risk of nonsentinel node metastases (NSNM) in this systematic review and meta-analysis.
The State of Melanoma: Emergent Challenges and Opportunities
Five years ago, the Melanoma Research Foundation (MRF) conducted an assessment of the challenges and opportunities facing the melanoma research community and patients with melanoma.
FDA Grants Orphan Drug Designation to Novel Immunotherapy in Advanced Melanoma
The FDA has granted an Orphan Drug designation to the novel immunotherapy PVSRIPO for the treatment of patients with advanced melanoma of stage IIB-IV, Istari Oncology, Inc., announced in a press release.1